Levosimendan in cardiac surgery

Authors: MUDr. Petr Pavlík
Authors‘ workplace: Centrum kardiovaskulární a transplantační chirurgie, Brno petr. pavlik@cktch. cz
Published in: Kardiol Rev Int Med 2013, 15(1): 59-61


Levosimendan in cardiac surgery. The calcium-sensitizing agent Levosimendan presents a thera­peutic option in the treatement of heart failure of different ethiology. Inotropic properties of levosimendan are similar as those of commonly used catecholamines, its haemodynamic effects are superior and prolonged without severe side effects. Because of its elevated price many effort was done to identify patients susceptible to benefit of its administration. The cardiosurgical patient and cardiosurgical procedures are likely to be complicated by cardiac failure. Using data of literature we try to present rational indications of levosimendan in cardiac surgery.

heart failure – levosimendan – inotropic agents – cardiac surgery


1. Slawsky MT, Colucci WS, Gottlieb SS et al. Acute hemodynamic and clinical effects of levosimendan in patient with severe heart failure. Study Investigators. Circulation 2000; 102: 2222–2227.

2. Moiseyev VS, Poder P, Andrejevs N et al. RUSSLAN Study Investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002; 23: 1422–1432.

3. Follath F, Cleland JG, Just H et al. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared to dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196–202.

4. García-González MJ, Domínguex-Rodríguez A, Ferrer-Hita JJ et al. Cardiogenic shock after percutaneous coronary intervention: effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail 2006; 8: 723–728.

5. Mebazaa A, Nieminen MS, Packer M et al. SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007; 297: 1883–1891.

6. Adamopoulos S, Parissis JT, Iliodromitis EK et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol 2006; 98: 102–106.

7. Paparella D, Scrascia G, Paramythiotis A et al. Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patiens with recent myocardial infarction. Ann Thorac Surg 2010; 89: 696–702.

8. Szilágyi S, Pollesello P, Levijoki J et al. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. Eur J Pharmacol 2004; 486: 67–74.

9. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104: 556–569.

10. Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care 2011; 15: R140.

11. Tritapepe L, De Santis V, Vitale D et al. Levosimendan pre-treatment improves outcomes in pa­tients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102: 198–204.

12. De Hert SG, Lorsomradee S, vanden Eede H et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 2008; 22: 699–705.

13. De Hert SG, Lorsomradee S, Cromheecke S et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766–773.

14. Mebazaa A, Karpati P, Renaud E et al. Acute right ventricular failure – from pathophysiology to new treatments. Intensive Care Med 2004; 30: 185–196.

15. Parissis JT, Paraskevaidis I, Bistola V et al. Effects of levosimendan on right ventricular function in pa­tients with advanced heart failure. Am J Cardiol 2006; 98: 1489–1492. Epub 2006 Oct 13.

16. Beiras-Fernandez A, Weis FC, Kur F et al. Primary graft failure and Ca2+ sensitizers after heart transplantation. Transplant Proc 2008; 40: 951–952.

Paediatric cardiology Cardiac surgery Cardiology
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account